Benzinga's Top Upgrades, Downgrades For November 5, 2019

Loading...
Loading...

Upgrades

  • Rosenblatt upgraded the stock for Applied Optoelectronics Inc AAOI from Neutral to Buy. Applied Optoelectronics earned ($0.26) in the second quarter, compared to $0.64 in the year-ago quarter. Applied Optoelectronics's market cap stands at $224.7 million. The stock has a 52-week-high of $23.38 and a 52-week-low of $8.34. Applied Optoelectronics's stock last closed at $10.60 per share.
  • For AECOM ACM, Deutsche Bank upgraded the stock from Hold to Buy. AECOM earned $0.72 in the third quarter, compared to $0.62 in the year-ago quarter. The current market cap for AECOM is at $5.8 billion. The stock has a 52-week-high of $41.85 and a 52-week-low of $24.83. AECOM's stock last closed at $41.64 per share.
  • Mizuho changed the rating for Autoliv Inc ALV from Neutral to Buy. In the third quarter, Autoliv showed an EPS of $1.30, compared to $1.35 from the year-ago quarter. The current market cap for Autoliv is at $6.8 billion. The stock has a 52-week-high of $91.00 and a 52-week-low of $61.07. Autoliv's stock last closed at $82.74 per share.
  • Cantor Fitzgerald changed the rating for Amgen Inc AMGN from Neutral to Overweight. For the third quarter, Amgen had an EPS of $3.66, compared to year-ago quarter EPS of $3.69. Amgen's market cap stands at $115.3 billion. The stock has a 52-week-high of $219.84 and a 52-week-low of $166.30. Amgen's stock last closed at $214.41 per share.
  • Bernstein upgraded the stock for Beyond Meat Inc BYND from Market Perform to Outperform. Beyond Meat earned $0.06 in the third quarter. Beyond Meat's market cap stands at $5.1 billion. The stock has a 52-week-high of $239.71 and a 52-week-low of $45.00. Beyond Meat's stock last closed at $79.79 per share.
  • Credit Suisse changed the rating for Chubb Ltd CB from Underperform to Outperform. For the third quarter, Chubb had an EPS of $2.70, compared to year-ago quarter EPS of $2.41. Chubb's market cap stands at $69.0 billion. The stock has a 52-week-high of $162.44 and a 52-week-low of $119.54. Chubb's stock last closed at $147.71 per share.
  • For Chegg Inc CHGG, Citigroup upgraded the stock from Neutral to Buy. In the third quarter, Chegg showed an EPS of $0.18, compared to $0.07 from the year-ago quarter. Chegg's market cap stands at $3.9 billion. The stock has a 52-week-high of $48.22 and a 52-week-low of $23.21. Chegg's stock last closed at $29.33 per share.
  • Bank of America upgraded the stock for EverQuote Inc EVER from Underperform to Buy. In the third quarter, EverQuote showed an EPS of $0.01, compared to ($0.15) from the year-ago quarter. EverQuote's market cap stands at $550.7 million. The stock has a 52-week-high of $25.22 and a 52-week-low of $4.05. EverQuote's stock last closed at $21.77 per share.
  • For Facebook Inc FB, Daiwa Capital upgraded the stock from Outperform to Buy. For the third quarter, Facebook had an EPS of $2.12, compared to year-ago quarter EPS of $1.76. The total market value of Facebook's outstanding shares is at $546.5 billion. The stock has a 52-week-high of $208.66 and a 52-week-low of $123.02. Facebook's stock last closed at $194.72 per share.
  • For FBL Financial Group Inc FFG, Raymond James upgraded the stock from Underperform to Market Perform. For the third quarter, FBL Financial Group had an EPS of $1.02, compared to year-ago quarter EPS of $1.28. The current market cap for FBL Financial Group is at $1.4 billion. The stock has a 52-week-high of $72.21 and a 52-week-low of $52.91. FBL Financial Group's stock last closed at $56.88 per share.
  • For First Horizon National Corp FHN, Bank of America upgraded the stock from Neutral to Buy. In the third quarter, First Horizon National showed an EPS of $0.43, compared to $0.36 from the year-ago quarter. First Horizon National's market cap stands at $5.0 billion. The stock has a 52-week-high of $16.96 and a 52-week-low of $12.30. First Horizon National's stock last closed at $16.84 per share.
  • Piper Jaffray changed the rating for Fulgent Genetics Inc FLGT from Neutral to Overweight. For the third quarter, Fulgent Genetics had an EPS of $0.14, compared to year-ago quarter EPS of $0.00. The total market value of Fulgent Genetics's outstanding shares is at $203.5 million. The stock has a 52-week-high of $12.88 and a 52-week-low of $3.02. Fulgent Genetics's stock last closed at $9.40 per share.
  • Barclays upgraded the stock for Halozyme Therapeutics Inc HALO from Underweight to Equal-Weight. For the second quarter, Halozyme Therapeutics had an EPS of ($0.10), compared to year-ago quarter EPS of ($0.16). The total market value of Halozyme Therapeutics's outstanding shares is at $2.3 billion. The stock has a 52-week-high of $17.79 and a 52-week-low of $13.24. Halozyme Therapeutics's stock last closed at $15.45 per share.
  • Mizuho upgraded the stock for NXP Semiconductors NV NXPI from Neutral to Buy. In the third quarter, NXP Semiconductors showed an EPS of $2.02, compared to $2.01 from the year-ago quarter. NXP Semiconductors's market cap stands at $30.4 billion. The stock has a 52-week-high of $119.89 and a 52-week-low of $67.62. NXP Semiconductors's stock last closed at $117.88 per share.
  • For Sientra Inc SIEN, William Blair upgraded the stock from Market Perform to Outperform. In the second quarter, Sientra showed an EPS of ($0.73), compared to ($0.73) from the year-ago quarter. Sientra's market cap stands at $338.6 million. The stock has a 52-week-high of $22.28 and a 52-week-low of $4.78. Sientra's stock last closed at $6.77 per share.

 

Downgrades

  • Barclays changed the rating for American Axle & Mfg Holdings Inc AXL from Overweight to Equal-Weight. In the third quarter, American Axle & Mfg Hldgs showed an EPS of $0.58, compared to $0.63 from the year-ago quarter. The total market value of American Axle & Mfg Hldgs's outstanding shares is at $940.2 million. The stock has a 52-week-high of $17.20 and a 52-week-low of $5.87. American Axle & Mfg Hldgs's stock last closed at $11.05 per share.
  • Cowen & Co. changed the rating for CAI International Inc CAI from Outperform to Market Perform. CAI International earned $0.74 in the third quarter, compared to $1.03 in the year-ago quarter. The total market value of CAI International's outstanding shares is at $379.3 million. The stock has a 52-week-high of $26.63 and a 52-week-low of $17.87. CAI International's stock last closed at $23.80 per share.
  • Oppenheimer downgraded the stock for Ceragon Networks Ltd CRNT from Outperform to Perform. Ceragon Networks earned $0.01 in the third quarter, compared to $0.07 in the year-ago quarter. The total market value of Ceragon Networks's outstanding shares is at $207.7 million. The stock has a 52-week-high of $5.04 and a 52-week-low of $1.90. Ceragon Networks's stock last closed at $1.91 per share.
  • For FirstEnergy Corp FE, Morgan Stanley downgraded the stock from Overweight to Equal-Weight. FirstEnergy earned $0.76 in the third quarter, compared to $0.80 in the year-ago quarter. The current market cap for FirstEnergy is at $26.1 billion. The stock has a 52-week-high of $49.07 and a 52-week-low of $35.33. FirstEnergy's stock last closed at $48.00 per share.
  • Keefe, Bruyette & Woods changed the rating for Heritage Insurance Holdings Inc HRTG from Outperform to Market Perform. Heritage Insurance Hldgs earned $0.28 in the third quarter, compared to $0.23 in the year-ago quarter. The current market cap for Heritage Insurance Hldgs is at $397.6 million. The stock has a 52-week-high of $16.95 and a 52-week-low of $12.88. Heritage Insurance Hldgs's stock last closed at $14.79 per share.
  • Bank of America changed the rating for Hudson Ltd HUD from Neutral to Underperform. For the third quarter, Hudson had an EPS of $0.26, compared to year-ago quarter EPS of $0.41. The total market value of Hudson's outstanding shares is at $1.1 billion. The stock has a 52-week-high of $21.15 and a 52-week-low of $10.33. Hudson's stock last closed at $12.41 per share.
  • B. Riley changed the rating for National CineMedia Inc NCMI from Buy to Neutral. National CineMedia earned $0.12 in the third quarter, compared to $0.14 in the year-ago quarter. The total market value of National CineMedia's outstanding shares is at $666.5 million. The stock has a 52-week-high of $8.93 and a 52-week-low of $5.88. National CineMedia's stock last closed at $8.48 per share.
  • Wells Fargo downgraded the stock for Owl Rock Capital Corp ORCC from Market Perform to Underperform. Owl Rock Capital earned $0.36 in the third quarter. Owl Rock Capital's market cap stands at $6.1 billion. The stock has a 52-week-high of $18.15 and a 52-week-low of $15.02. Owl Rock Capital's stock last closed at $17.19 per share.
  • RBC Capital downgraded the stock for Pattern Energy Group Inc PEGI from Outperform to Sector Perform. For the third quarter, Pattern Energy Group had an EPS of ($0.39), compared to year-ago quarter EPS of ($0.13). The total market value of Pattern Energy Group's outstanding shares is at $2.6 billion. The stock has a 52-week-high of $28.50 and a 52-week-low of $17.52. Pattern Energy Group's stock last closed at $27.11 per share.
  • Wells Fargo downgraded the stock for Prudential Financial Inc PRU from Outperform to Market Perform. In the third quarter, Prudential Financial showed an EPS of $3.22, compared to $3.15 from the year-ago quarter. Prudential Financial's market cap stands at $36.8 billion. The stock has a 52-week-high of $106.39 and a 52-week-low of $75.61. Prudential Financial's stock last closed at $94.64 per share.
  • Raymond James changed the rating for Charles Schwab Corp SCHW from Outperform to Market Perform. In the third quarter, Charles Schwab showed an EPS of $0.74, compared to $0.65 from the year-ago quarter. Charles Schwab's market cap stands at $53.2 billion. The stock has a 52-week-high of $49.24 and a 52-week-low of $34.58. Charles Schwab's stock last closed at $43.24 per share.

 

Initiations

  • BWS Financial initiated coverage on Anika Therapeutics Inc ANIK with a Sell rating. The price target for Anika Therapeutics is set at $29.00. For the third quarter, Anika Therapeutics had an EPS of $0.64, compared to year-ago quarter EPS of $0.53. The total market value of Anika Therapeutics's outstanding shares is at $783.2 million. The stock has a 52-week-high of $75.72 and a 52-week-low of $29.01. Anika Therapeutics's stock last closed at $66.73 per share.
  • Credit Suisse initiated coverage on Apellis Pharmaceuticals Inc APLS with a Neutral rating. The price target for Apellis Pharmaceuticals is set at $33.00. In the third quarter, Apellis Pharmaceuticals showed an EPS of ($1.09), compared to ($0.64) from the year-ago quarter. The total market value of Apellis Pharmaceuticals's outstanding shares is at $1.5 billion. The stock has a 52-week-high of $33.18 and a 52-week-low of $12.16. Apellis Pharmaceuticals's stock last closed at $30.61 per share.
  • With a rating of Neutral, Credit Suisse initiated coverage on argenx SE ARGX. The price target is set at $137.00 for argenx. argenx earned ($0.72) in the third quarter. The stock has a 52-week-high of $150.92 and a 52-week-low of $82.93. argenx's stock last closed at $127.65 per share.
  • With a rating of Outperform, Wolfe Research initiated coverage on Arqule Inc ARQL. The price target is set at $17.00 for Arqule. In the third quarter, Arqule showed an EPS of ($0.09), compared to ($0.05) from the year-ago quarter. The total market value of Arqule's outstanding shares is at $1.2 billion. The stock has a 52-week-high of $12.22 and a 52-week-low of $2.23. Arqule's stock last closed at $9.69 per share.
  • Wolfe Research initiated coverage on BioNTech SE BNTX with an Outperform rating. The price target for BioNTech is set at $21.00. The stock has a 52-week-high of $21.99 and a 52-week-low of $12.53. BioNTech's stock last closed at $18.97 per share.
  • With a rating of Neutral, JP Morgan initiated coverage on HBT Financial Inc HBT. The price target is set at $17.00 for HBT Financial. The stock has a 52-week-high of $16.40 and a 52-week-low of $15.27. HBT Financial's stock last closed at $16.06 per share.
  • Keefe, Bruyette & Woods initiated coverage on HBT Financial Inc HBT with an Outperform rating. The price target for HBT Financial is set at $21.00. The stock has a 52-week-high of $16.40 and a 52-week-low of $15.27. HBT Financial's stock last closed at $16.06 per share.
  • With a rating of Outperform, Raymond James initiated coverage on HBT Financial Inc HBT. The price target is set at $18.00 for HBT Financial. The stock has a 52-week-high of $16.40 and a 52-week-low of $15.27. HBT Financial's stock last closed at $16.06 per share.
  • With a rating of Buy, H.C. Wainwright initiated coverage on aTyr Pharma Inc LIFE. The price target is set at $8.00 for aTyr Pharma. aTyr Pharma earned ($1.80) in the second quarter. The current market cap for aTyr Pharma is at $13.6 million. The stock has a 52-week-high of $11.48 and a 52-week-low of $2.76. aTyr Pharma's stock last closed at $3.73 per share.
  • With a rating of Buy, H.C. Wainwright initiated coverage on PDS Biotechnology Corp PDSB. The price target is set at $7.00 for PDS Biotechnology. PDS Biotechnology's market cap stands at $27.2 million. The stock has a 52-week-high of $17.00 and a 52-week-low of $2.80. PDS Biotechnology's stock last closed at $3.05 per share.
  • Credit Suisse initiated coverage on uniQure NV QURE with an Outperform rating. The price target for uniQure is set at $76.00. In the third quarter, uniQure showed an EPS of ($0.58), compared to ($0.59) from the year-ago quarter. uniQure's market cap stands at $1.4 billion. The stock has a 52-week-high of $82.49 and a 52-week-low of $21.98. uniQure's stock last closed at $49.58 per share.
  • Stephens & Co. initiated coverage on The Rubicon Project Inc RUBI with an Overweight rating. The price target for Rubicon Project is set at $12.00. In the second quarter, Rubicon Project showed an EPS of ($0.06), compared to ($0.27) from the year-ago quarter. Rubicon Project's market cap stands at $470.5 million. The stock has a 52-week-high of $10.85 and a 52-week-low of $3.00. Rubicon Project's stock last closed at $8.44 per share.
  • Stephens & Co. initiated coverage on SkyWest Inc SKYW with an Overweight rating. The price target for SkyWest is set at $75.00. SkyWest earned $1.79 in the third quarter, compared to $1.57 in the year-ago quarter. The total market value of SkyWest's outstanding shares is at $2.9 billion. The stock has a 52-week-high of $63.40 and a 52-week-low of $42.38. SkyWest's stock last closed at $61.46 per share.
 
 
 
Loading...
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsInformation TechnologyInitiationsIT Consulting & Other Servicestop upgrades
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...